uniQure NV Stock Price - QURE

44.00
-0.26 (-0.59%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
uniQure NV QURE NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.69 -1.54% 44.26 42.90 45.7899 42.90 44.95 20:00:00
Bid Price Ask Price Spread Spread % News
26.00 65.00 39.00 60.0% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,983 204,951 $ 44.47 $ 9,114,524 451,767 36.20 - 82.49
Last Trade Time Type Quantity Stock Price Currency
16:23:02 5 $ 44.00 USD

uniQure NV Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.96B 44.27M $ -83.30M -3.12 - 43.17M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

uniQure NV News

Loading Messages....

Latest QURE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QURE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week44.4046.0239.4343.73400,509-0.14-0.32%
1 Month48.7858.4737.5046.81478,443-4.52-9.27%
3 Months68.9376.686937.5058.09473,365-24.67-35.79%
6 Months41.4876.686936.2056.67502,5822.786.7%
1 Year60.0082.4936.2060.18560,865-15.74-26.23%
3 Years5.7882.494.7241.16442,03038.48665.74%
5 Years24.6582.494.7233.54385,58719.6179.55%

uniQure NV Description

uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers-Squibb for cardiovascular diseases.


Your Recent History
NASDAQ
QURE
uniQure NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.